Antiproliferative Effect of Okra Seed Protein Isolate against HepG2 and A549 Cell Lines
Abstract Cancer is a non‐communicable disease and is one of the leading causes of mortality worldwide. While plant‐derived compounds have exhibited promise in cancer therapy, the biological activity of okra seed protein isolate (OSPI) has not been extensively explored. The present study evaluates the antiproliferative effect of OSPI against human liver hepatocellular carcinoma (HepG2) and lung adenocarcinoma (A549) cancer cell lines using in vitro assays. The protein isolate exhibited cytotoxic effects by reducing A549 cell viability significantly (37.73%), with an
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in